GYNECOLOGY
FRIDAY, NOVEMBER 25

08:30-10:00

DILEMMAS IN BENIGN GYNAECOLOGY

HALL B

Capsule

Dilemmas in daily care, which you have to deal with. Concerning adnexal masses and heavy menstrual bleeding

Chairpersons

Justin Clark, UK
Peggy Geomini, Netherlands

What is the best referral policy for patients with an adnexal mass?
Peggy Geomini, Netherlands

 

Differentiating benign form malignant cyst >> how to recognize less common types of benign adnexal masses (struma ovarii/ Brenner tumor/ Sertoli Leydig cell)
TBA

 

Treatment options in case of HMB with intramural fibroids?
Tessel Cooijmans, Netherlands

 

Is TLH really superior to abdominal hysterectomy ?
Justin ClarkUK

Endometrial ablation under local anesthetics – is it feasible?
Sergio Haimovich, Israel

 

10:00-10:20 Coffee break,  e-poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50

UTERINE MALFORMATION 

HALL B

Capsule

Chairpersons

Peggy Geomini, Netherlands
TBA

T-Shaped, Y-Shaped, Dysmorophic – a real reproductive problem or a new trend
Sergio Haimovich, Israel

 

 

Debate: Dysmorphic Uterus, is it a real infertility problem? is the solution surgical?
Pro:TBA
It is a real infertility problem, but the solution is not surgical: Ben Mol, Australia
Discussion

Debate: Uterine septum in infertility: To treat or not to treat?
Pro: Jacques  Donnez, Belgium
Con: Justin Clark, UK
Discussion

 

Endometrial ablation under local anesthetics – is it feasible?
Sergio Haimovich, Israel

 

11:50-12:00 Break

 

12:00-13:30

INDUSTRY SUPPORTED SESSION

HALL B

 

13:30-14:30  Lunch break,  moderated e-posters and visit the exhibition Exhibition Area

 

14:30-16:30

MENOPAUSE

HALL B

Capsule

 

Chairpersons

Justin Clark, UK
Dorenda van Dijken, Netherlands

Endocrine disruptors in fertility
Christian Egarter , Austria

Debate: Should ovarian tissue reimplantation be considered for all women to postpone menopause
Yes: Jacques Donnez, Belgium
No: Mark Brincat, Malta
Discussion

Postmenopausal hormone treatment and the risk for malignancies
Johannes Ott, Austria

Can AMH predict menopause
Frank Broekmans, Netherlands

 

16:30-16:50  Coffee break,  e-poster viewing and visit the exhibition Exhibition Area

 

16:50-18:20

HRT

HALL B

Capsule

 

Chairpersons

Christian Egarter, Austria
TBA
Debate: Should androgens be routinely added to menopause treatment
Yes: Alessandra Graziottin, Italy
No: Dorenda van Dijken, Netherlands
Discussion
Debate: Hormone therapy started in premature or early menopause, should be continued for life to prevent chronic diseases
For: Nick Panay, UK
Against: Mark Brincat, Malta
Discussion

Postmenopausal hormone treatment and the bone
Johannes Ott, Austria